
Hutchison China MediTech Limited HCM
€ 12.12
0.39%
Hutchison China MediTech Limited Gesamtverbindlichkeiten | HCM
Gesamtverbindlichkeiten Jährlich Hutchison China MediTech Limited
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 502 M | 502 M | 536 M | 393 M | 333 M | 205 M | 152 M | 120 M | 94.5 M | 138 M | 127 M | 99.1 M | 80.8 M | 126 M | 117 M |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 536 M | 80.8 M | 235 M |
Gesamtverbindlichkeiten Vierteljährlich Hutchison China MediTech Limited
| 2025-Q4 | 2025-Q2 | 2024-Q4 | 2024-Q2 | 2023-Q4 | 2023-Q2 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 502 M | 534 M | 502 M | 509 M | 536 M | 497 M | - | - | - | - | 333 M | - | 259 M | - | 205 M | - | 159 M | - | 152 M | 116 M | 122 M | 139 M | 120 M | - | 120 M | - | 113 M | - | 133 M | - | 138 M | - | - | - | 127 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Alle Zahlen in USD-Währung
Indikatorspanne aus vierteljährlicher Berichterstattung
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 536 M | 113 M | 266 M |
Gesamtverbindlichkeiten anderer Aktien in der Pharmaeinzelhändler
| Name | Gesamtverbindlichkeiten | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
Celsion Corporation
CLSN
|
5.23 M | - | -6.63 % | $ 13.9 M | ||
|
FSD Pharma
HUGE
|
6.06 M | - | 5743.5 % | $ 69.7 M | ||
|
Synthetic Biologics
SYN
|
22.9 M | - | 1.32 % | $ 16.2 M | ||
|
Dynavax Technologies Corporation
DVAX
|
389 M | - | - | $ 2.02 B | ||
|
I-Mab
IMAB
|
895 M | - | - | $ 866 M | ||
|
Corner Growth Acquisition Corp.
COOL
|
297 K | - | -0.89 % | $ 114 M | ||
|
AgeX Therapeutics
AGE
|
6.99 M | - | -10.17 % | $ 12.2 K | ||
|
Alexion Pharmaceuticals, Inc.
ALXN
|
6.45 B | - | - | $ 40.3 B | ||
|
Qilian International Holding Group Limited
QLI
|
41.9 M | - | -6.08 % | $ 184 M | ||
|
Happiness Biotech Group Limited
HAPP
|
3.86 M | - | 1.35 % | $ 17.8 M | ||
|
Genfit SA
GNFT
|
215 M | - | 2.54 % | $ 160 B | ||
|
Biophytis SA
BPTS
|
20.4 M | - | -13.47 % | $ 169 M | ||
|
CureVac N.V.
CVAC
|
106 M | - | - | $ 867 M | ||
|
EyeGate Pharmaceuticals, Inc.
EYEG
|
8.16 M | - | -1.52 % | $ 24.7 M | ||
|
Athira Pharma
ATHA
|
64.4 M | - | - | $ 269 M | ||
|
BiondVax Pharmaceuticals Ltd.
BVXV
|
71.5 M | - | 0.74 % | $ 768 M | ||
|
Abcam plc
ABCM
|
330 M | - | - | $ 4.9 B | ||
|
Завод ДИОД
DIOD
|
195 M | - | - | - | ||
|
Galera Therapeutics
GRTX
|
645 K | - | -32.59 % | $ 7.61 M | ||
|
Midatech Pharma plc
MTP
|
6.77 M | - | -18.52 % | $ 27.3 M | ||
|
Hepion Pharmaceuticals
HEPA
|
402 K | - | -18.79 % | $ 39.3 K | ||
|
ARCA biopharma
ABIO
|
16.7 M | - | 1052.0 % | $ 415 M | ||
|
MorphoSys AG
MOR
|
1.98 B | - | 2.43 % | $ 254 M | ||
|
Codexis
CDXS
|
97.3 M | $ 1.46 | 2.82 % | $ 127 M | ||
|
Ardelyx
ARDX
|
335 M | $ 3.78 | 1.89 % | $ 911 M | ||
|
Affimed N.V.
AFMD
|
104 M | - | -34.95 % | $ 21.5 M | ||
|
Arcutis Biotherapeutics
ARQT
|
243 M | $ 23.9 | 1.01 % | $ 3.04 B | ||
|
Assembly Biosciences
ASMB
|
50.8 M | $ 36.6 | 1.3 % | $ 410 M | ||
|
AnPac Bio-Medical Science Co., Ltd.
ANPC
|
49.9 M | - | -1.58 % | $ 28.1 M | ||
|
Celyad Oncology SA
CYAD
|
35.1 M | - | - | $ 12.5 M | ||
|
Adial Pharmaceuticals
ADIL
|
1.4 M | $ 7.12 | 6.91 % | $ 4.76 M | ||
|
Generation Bio Co.
GBIO
|
145 M | - | - | $ 344 M | ||
|
Akero Therapeutics
AKRO
|
75.8 M | - | - | $ 3.67 B | ||
|
Cyclacel Pharmaceuticals
CYCCP
|
1.34 M | - | -4.36 % | $ 27 M | ||
|
Gracell Biotechnologies
GRCL
|
281 M | - | - | $ 3.37 B | ||
|
Axsome Therapeutics
AXSM
|
602 M | $ 206.68 | 0.16 % | $ 10.3 B | ||
|
GlycoMimetics
GLYC
|
37.3 M | - | 9357.83 % | $ 1.01 B | ||
|
AnaptysBio
ANAB
|
30.2 M | $ 56.8 | 0.94 % | $ 1.63 B | ||
|
Aeterna Zentaris
AEZS
|
17.6 M | - | 5.93 % | $ 314 M | ||
|
AVROBIO
AVRO
|
9.71 M | - | 1083.1 % | $ 745 M | ||
|
BioMarin Pharmaceutical
BMRN
|
1.51 B | $ 66.53 | 0.15 % | $ 12.8 B | ||
|
BeiGene, Ltd.
BGNE
|
3.83 B | - | 0.49 % | $ 251 B | ||
|
AIkido Pharma
AIKI
|
43.5 M | - | 1.93 % | $ 17.4 M | ||
|
Aeglea BioTherapeutics
AGLE
|
62.5 M | - | - | $ 1.01 B | ||
|
Aptose Biosciences
APTO
|
37.2 M | - | -45.71 % | $ 1.2 M | ||
|
Bicycle Therapeutics plc
BCYC
|
108 M | $ 4.3 | 1.42 % | $ 298 M | ||
|
AlloVir
ALVR
|
42.9 M | - | 4.14 % | $ 49.1 M | ||
|
ChromaDex Corporation
CDXC
|
29.9 M | - | -0.88 % | $ 598 M |